دورية أكاديمية

Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety.

التفاصيل البيبلوغرافية
العنوان: Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety.
المؤلفون: Markman, John D., Bolash, Robert B., McAlindon, Timothy E., Kivitz, Alan J., Pombo-Suarez, Manuel, Seiji Ohtori, Roemer, Frank W., Li, David J., Viktrup, Lars, Bramson, Candace, West, Christine R., Verburg, Kenneth M., Ohtori, Seiji
المصدر: PAIN; Sep2020, Vol. 161 Issue 9, p2068-2078, 11p
قاعدة البيانات: Complementary Index
الوصف
تدمد:03043959
DOI:10.1097/j.pain.0000000000001928